PepJunkie Home of the Peptonauts
More

Peptide Atlas · Mineral

Sodium selenite

In the SISPCT trial of 1,089 patients with severe sepsis or septic shock, high-dose intravenous sodium selenite did not lower 28-day mortality (28.3% against 25.5% on placebo).

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 3 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No personal-experience post names it yet. When a member describes their own experience, PACIFIER reads it as such and it is listed here — labelled as experience, never as advice.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.